Suboxone Clinic South FloridaOpioid Detox Treatment at American Medical Management with Suboxone (Buprenorphine)

American Medical Management offers suboxone treatment with two detox specialists who are specifically licensed in the therapy. Suboxone is also known as buprenorphSuboxone Doctor Fort Lauderdaleine, and offers patients the opportunity to “kick” the opiate habit as an outpatient under the care of South Florida detox physicians who are highly versed in how to best manage your withdrawal.

Dr. Leonard Pace and Dr. Laurence Skolnik see patients who have a desire to safely quit using opiates, and do not have the time, desire, or resources to become an inpatient to accomplish the goal. Suboxone is a safe medication that allows the patient to complete treatment while staying in one’s home surrounded by family and friends.

Call American Medical Management today at  (954) 399-6945 to enroll in the outpatient program with Drs. Skolnik and  Pace and learn about the affordibility of the treatment and how it works. Suboxone has been shown to be extremely helpful RBK12020for patients addicted to all kinds of opiates including morphine, heroin, methadone and more.

Suboxone Outpatient Detox Fees:
*Initial Visit: $250
Weekly visit: $75
Monthly Follow up Visit after 90-day evaluation: $250

FAQs on Suboxone

What is suboxone?

Suboxone is a medication formulated as a combination of buprenorphine and naloxone. Other known formulations similar to suboxone include brand names such as Subutex, and Zubsolv (buprenorphine HCl and ornaloxone HCl).

SubImg_1Buprenorphine is used for the treatment of opioid addiction in higher doses, or to control acute and chronic pain at lower doses.[1] It is a semi-synthetic, mixed agonist-antagonist opioid receptor modulator.[2] Naloxone blocks the effect of narcotics, causing severe narcotic withdrawal when injected.

While this drug has minimal effect when taken orally, the combination with buprenorphine in suboxone is a precaution against the potential abuse of this drug (i.e., injection).

What is Suboxone Film?

Suboxone Film is an effective and discreet treatment for narcotic dependence. You can start your treatment in a South Florida detox specialist’s office and then take Suboxone Film home to use!

The medication in SUBOXONE Film is absorbed into the bloodstream through blood vessels under your tongue.

Who should be prescribed suboxone?

Suboxone has been successfully used in the treatment of addiction to opioids, such as morphine.[3] Patients with addictions to long-acting opioid products such as methadone, and short-acting opioids such as heroin, have also been successfully treated with suboxone.[4]Bayer_Heroin_bottle

Here is a list of those who can benefit outpatient South Florida detox treatment with Suboxone:

  • Opioids
  • Methadone
  • Benzodiazepines
  • Heroin
  • Cocaine

How is suboxone prescribed?

There are various ways to prescribe Suboxone, and the dosage will vary according to patient needs. The dosage is progressively adjusted to an appropriate level where the patient is kept in treatment, and the opioid withdrawal signs and symptoms are held in abeyance.

Complete Care Medical’s Suboxone Certified detox specialists will discuss the best method of prescribing the medication for your needs at the time of your initial visit.

How is suboxone taken?

The drug is taken sublingually (i.e., placed under the tongue for faster absorption). For regimens that require more than two tablets, the patient is advised to either place all the suboxonetablets sublingually, or in batches of two.

The tablets are dissolved within 5 to 10 minutes after placing them under the tongue. Patients should be reminded that suboxone needs to be taken sublingually to maximize the bioavailability of the drug. Patients are advised to avoid chewing or swallowing the tablets, in order to avoid the first-pass metabolizing effect of the liver.

The treatment with suboxone should be initiated under supervised administration. As the clinical stability of the patient is assessed, this can progress to unsupervised administration. A clear evaluation of the patient’s stability and likelihood of recidivism should be made prior to allowing unsupervised administration.

Patients should be seen at regular follow-up intervals, which will extend as the patient exhibits better signs of stability. Multiple refills are not prescribed during the early weeks of treatment.

What are the side effects of suboxone?

The numerous adverse drug reactions that are associated with suboxone are related to its component drugs. The patient may react to suboxone by exhibiting signs of adverse reactions similar to other opioids, including nausea and vomiting, drowsiness, dizziness, headache, memory loss, cognitive and neural inhibition, perspiration, itchiness, dry mouth, miosis, orthostatic hypotension, male ejaculatory difficulty, decreased libido, and urinary retention. Other symptoms include chills, problems with micturition, bloating or weight gain, flushing on the face and neck and tingling of the hands and feet.

If suboxone has been used for extended periods of time, or in high doses, there may be withdrawal symptoms from the sudden cessation of the drug. These include restlessness, watering eyes, runny nose, nausea, sweating, muscle aches. The dose needs to be tapered off gradually to avoid complications from the withdrawal reactions.

The presence of any of the following symptoms may warrant referral to a health care professional at the emergency department. The following symptoms indicate a possible overdose of suboxone:

  • Blurring of visionsuboxone3
  • Confusion
  • Dyspnea (difficulty breathing)
  • The subjective feeling of dizziness, faintness, or lightheadedness when standing or arising rapidly from a lying or recubent position
  • Persistent drowsiness or sleepiness
  • Irregularities breathing
  • Cyanosis of the lips, fingernails or skin
  • Pinpoint pupils

There are numerous, less common adverse reactions, including: auditory and visual hallicinations, hepatotoxicity, hyperacidity, constipation, among others. However, the side effects of suboxone, especially when taken within the appropriate dosage, are mostly mild and can disappear as the body gets used to taking the medication.

The most severe adverse reaction associated with suboxone, and opioids in general, is the respiratory depression. This is the mechanism that usually results from the fatal overdose of the patient. Suboxone should never be used with CNS depressents (alcohol or benzodiazepines) because of the risk of respiratory depression.

What happens if a dose of suboxone is missed?

If one dose of suboxone is missed, then it should be taken as soon as the missed dose is remembered. However, if it is more practical to wait until the next dose (e.g., when it is remembered close to the next dose), then it is advised that the next dose be taken during the usual time. Because of the risk for respiratory depression, patients are advised against taking an extra tablet to “make up” for the missed dose.

What should be avoided while taking suboxone?

It is strongly advised that patients completely avoid alcohol, benzodiazepines, and other CNS depressants that can interact with suboxone and cause fatal respiratory depression. It is advised that patients avoid operating heavy machinery or driving until they have confirmed that the medication does not cause them drowsiness or sleepiness.

 

[1] Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ (1996). “Buprenorphine and naloxone interactions in opiate-dependent volunteers*”. Clinical Pharmacology & Therapeutics 60 (1): 105–114. doi:10.1016/S0009-9236(96)90173-3. PMID 8689806

[2] Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3.

[3] Fudala PJ, Yu E, Macfadden W, Boardman C, Chiang CN (1998). “Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts”. Drug and Alcohol Dependence 50 (1): 1–8. doi:10.1016/S0376-8716(98)00008-8. PMID 9589267

[4] Strain EC, Preston KL, Liebson IA, Bigelow GE (1992). “Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers”. The Journal of Pharmacology and Experimental Therapeutics 261 (3): 985–993.